INOVIO Announces Pricing of $17.5 Million Public Offering

B PLYMOUTH MEETING, Pa., April 2, 2026 /PRNewswire/ — INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help…
posteditor
posteditor
Articles: 16137